NCT03674138View on ClinicalTrials.gov

Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

September 12, 2018

Primary Completion Date

September 3, 2021

Study Completion Date

October 27, 2024

Conditions
DepressionAnxietyGeneralized Anxiety DisorderDepressive DisorderMajor Depressive DisorderCancer
Interventions
DIAGNOSTIC_TEST

DNA-guided choice of therapy

Buccal swab for DNA genotyping to identify best antidepressant therapy

OTHER

Clinical management

Clinical management to identify best antidepressant therapy

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT03674138 - Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients | Biotech Hunter | Biotech Hunter